News | August 01, 2023
Concord Biotech’s IPO to open on 4th August, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
ANVISA issues CGMP to Concord Biotech’s Unit I
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
According to ICMR, the upgraded OmiSure RT-PCR test for Covid-19 successfully detects all sub-types of Omicron that are currently prevalent in India
Subscribe To Our Newsletter & Stay Updated
